DaVita (NYSE:DVA) Reaches New 12-Month High – Here’s What Happened

DaVita Inc. (NYSE:DVA)’s stock price reached a new 52-week high on Tuesday . The company traded as high as $169.64 and last traded at $169.73, with a volume of 161278 shares. The stock had previously closed at $166.24.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on DVA shares. Truist Financial raised their price objective on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Barclays raised their price target on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $161.80.

DaVita Trading Up 2.2 %

The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The stock has a market capitalization of $13.93 billion, a PE ratio of 18.32, a price-to-earnings-growth ratio of 0.81 and a beta of 0.92. The business’s 50-day moving average is $157.35 and its two-hundred day moving average is $153.12.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). The business had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the business earned $2.85 earnings per share. As a group, equities research analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current year.

Hedge Funds Weigh In On DaVita

Institutional investors have recently modified their holdings of the company. Franklin Resources Inc. boosted its holdings in shares of DaVita by 134.6% in the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after purchasing an additional 31,502 shares during the last quarter. FMR LLC boosted its holdings in DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after acquiring an additional 154,061 shares during the last quarter. Atom Investors LP purchased a new stake in DaVita during the third quarter valued at about $4,094,000. Neo Ivy Capital Management acquired a new stake in DaVita during the third quarter worth about $726,000. Finally, Quest Partners LLC purchased a new position in shares of DaVita in the 3rd quarter worth about $669,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.